KLRS Q1 2020 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena

KLRSKalaris Therapeutics Inc

$180M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$18,000

Operating Income

-$10M

Net Income

-$9M

EPS (Diluted)

$-3.30

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$129M

Total Liabilities

$16M

Stockholders' Equity

$113M

Cash & Equivalents

$64M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$165,000	-100.0%
Gross Profit	-$18,000	$0	—
Operating Income	-$10M	-$3M	-254.9%
Net Income	-$9M	-$3M	-270.0%